HempFusion Announces New Chief Financial Officer
June 18 2021 - 4:15PM
Business Wire
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF)
(FWB:8OO) (“HempFusion” or the “Company”), a leading health and
wellness Company offering premium probiotic supplements and
products containing CBD, announces that it has promoted Maria Leal,
the Company’s Vice President and Controller, to Interim Chief
Financial Officer.
Ms. Leal holds a CPA and an MBA and has a strong track record in
financial management having served in various senior financial
accounting positions during her more than 20-year career. Ms. Leal
has been with HempFusion since July 2019 and has been instrumental
in all financial reporting aspects for the Company.
The Company would like to thank Mr. Bruce Valentine for his
service to HempFusion and wish him well in all future endeavors.
Mr. Valentine stepped down as Chief Financial Officer effective
June 16, 2021, due to the unexpected passing of his mother and the
resulting duties that have arisen.
“On behalf of the Company and the employees of HempFusion, we
send our deepest condolences to Bruce and his family for their
loss,” commented Jason Mitchell, N.D., Chief Executive Officer of
HempFusion. “I would like to thank Bruce for his contributions to
the Company. The Board has begun a process to appoint a successor
to Mr. Valentine and a further announcement will be made in due
course. In the meantime, the Board has full confidence that Ms.
Leal will succeed in shepherding HempFusion’s finance and
accounting functions. She has been an integral part of the
development and implementation of the financial planning and
accounting functions over the past several years.”
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition. HempFusion
distributes its family of brands, including HempFusion, Probulin
Probiotics, Biome Research, and HF Labs, to approximately 4,000
retail locations across all 50 states of the United States and
select international locations. Built on a foundation of regulatory
compliance and human safety, HempFusion’s diverse product portfolio
comprises 48 SKUs including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion’s
wholly-owned subsidiary, Probulin Probiotics, is one of the
fastest-growing probiotics companies in the United States,
according to SPINs reported data. HempFusion’s CBD products are
based on a proprietary Whole Food Hemp Complex™ and are available
in-store or by visiting HempFusion online at www.hempfusion.com or
www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and
Probulin on Twitter, Facebook and Instagram.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210618005486/en/
Jason Mitchell, N.D. Chief Executive Officer and Director Email:
ir@hempfusion.com Phone: 416-803-5638
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Mar 2024 to Apr 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Apr 2023 to Apr 2024